Sunday, February 10, 2019

primary efficacy

The primary objective was to establish the safety and tolerability of cannabidiol, and the primary efficacy result was the average percentage change in the average monthly frequency of motor seizures at 12 weeks.

The average monthly frequency of seizures was calculated in the clinic every 4 weeks as (number of seizures since the last visit) / (days since the last visit) × 28 CBD Gummies. The average percentage change was calculated because the patients had a wide range of seizure frequencies.

No comments:

Post a Comment